Posted 11th September 2019 by Joshua Sewell
Ahead of his presentation at the 6th Digital Pathology and AI Congress: Europe, we spoke to Andrew Janowczyk about his work creating scalable data analysis techniques to facilitate cancer research through the development of open-source Digital Pathology tools.
Posted 9th September 2019 by Joshua Sewell
As Chief Data Officer for the OSTHUS Group, Eric Little co-founded LeapAnalysis, a new approach to AI, data integration and analytics.
LeapAnalysis is the first fully federated and virtualised search and analytics engine that runs on semantic metadata. It allows users to combine semantic models (ontologies) with machine learning algorithms to provide customers with unparalleled flexibility in utilizing their data.
Posted 4th September 2019 by Liv Sewell
Most students and clinicians learn microbiology with the proper equipment: microscopes. However, in deprived countries front-line health facilities have to refer patients elsewhere because they do not have a microscope to enable diagnosis. Research is inhibited because of lack of equipment, students never get the opportunity to use real microscopes during their studies, and participation in science and particularly microbiology is very low.
Posted 30th August 2019 by Liv Sewell
NAFLD is the primary contributor to chronic liver disease worldwide with incident rates of 20-30% in western countries and 5-18% in Asia. The discovery of early stage biomarkers for patients with the reversible form of the disease is therefore a research priority. Recent work has shown perturbation of the microbiome and specific microbiome-associated metabolites contribute to the phenotype of NAFLD.
Posted 28th August 2019 by Jane Williams
Following the 5th Digital Pathology & AI Congress: USA, we have made the following presentation slides available from Iman Hajirasouliha, Kim Solez and Mrinal Mandal.
Posted 23rd August 2019 by Jane Williams
The Microbiome & Probiotics Series: Europe is one of the highlights of our calendar year. Kristin Neumann, author & founder of MyMicrobiome was one of our speakers on the cosmeceuticals track and was kind enough to write the following recap of the event, for people who weren’t able to attend this year. You can read the original article here.
Posted 19th August 2019 by Jane Williams
e-Therapeutics, an Oxford-based company, is using its network-driven drug discovery (NDD) technology to embrace the inherent complexity of biology, providing a novel and productive method for the discovery of new medicines.
Jonny Wray is the head of Discovery Informatics at e-Therapeutics. Trained as a computational neuroscientist, he is responsible for building the NDD technology. We spoke to him ahead of his presentation at the Global Pharma R&D Informatics & AI Congress.
Posted 16th August 2019 by Jane Williams
Andrew Cook has worked in the pharmaceutical industry for over 20 years. Throughout his career, he has endeavoured to do things differently, a little out of the ordinary, leading him to his work at H3 Biomedicine on splice modulators. “Part of the reason it attracted me” he says, “is it’s so different. It’s a natural product-based drug discovery effort, and I had never done that before”.